Author： Wan Yin Gao Xin Mehta Sonam Wang Zhixiao Faria Claudio Schwartzberg Lee
Publisher： Informa Healthcare
ISSN： 1369-6998
Source： Journal of Medical Economics, Vol.16, Iss.10, 2013-10, pp. : 1169-1178
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Lapatinib in metastatic breast cancer
By Frenel J-S Bourbouloux E Berton-Rigaud D Sadot-Lebouvier S Zanetti A Campone M
Women's Health, Vol. 5, Iss. 6, 2009-11 ,pp. :
Access to resources
Recommend
By Ray Saurabh Bonthapally Vijayveer McMorrow Donna Bonafede Machaon Landsman-Blumberg Pamela
Journal of Comparative Effectiveness Research, Vol. 2, Iss. 2, 2013-03 ,pp. :
Docetaxel Weekly with Metastatic Breast Cancer
Oncology Research and Treatment, Vol. 30, Iss. 8-9, 2007-09 ,pp. :
Xeloda® in the Treatment of Metastatic Breast Cancer
Oncology, Vol. 57, Iss. 1, 1999-07 ,pp. :
Capecitabine for the oral treatment of metastatic breast cancer
Women's Health, Vol. 2, Iss. 6, 2006-11 ,pp. :